Date Published 
December 2013

Page Count
107

Additional Info 
Single-site, country, and global licenses are multi-user, searchable, and cut-and-paste ready PDFs delivered by e-mail.

 Prenatal Diagnostics Europe 

For Corporate Subscriptions, Multi-Reports Orders, Discounts or Order Questions.  

Contact:
Kerri Kelley
Customer Service
781-972-1347 


IPR Bundle

Prenatal Diagnostic Testing - Table of Contents

Executive Summary

Part I: Prenatal Applications

CHAPTER 1: Invasive Testing

Karyotyping

Microarray analysis

CHAPTER 2: Noninvasive Testing

Sequence-based cell-free DNA testing

Fetal cell isolation

 

Part II: Noninvasive Prenatal Applications

CHAPTER 3: Sequenom

Company background

Areas of Research

MaterniT21™ PLUS

MaterniT21 PLUS validation

Competitive advantage

Future endeavors

Interview with William Welch; Dirk van den Boom; and Allan Bombard

  • Company background
  • Technologies in development
  • SEQureDx platform
  • MaterniT21 platform
  • Validation techniques
  • Areas of improvement
  • Competitive advantage
  • Customer feedback
  • Future endeavors

CHAPTER 4: Verinata Health

Company background

The verifi® prenatal test

Challenges encountered

Clinical validation and reimbursement

Customer feedback

Interview with Richard Rava

  • Company background
  • verifi® prenatal test
  • Challenges encountered
  • Competitive advantage

CHAPTER 5: Ariosa Diagnostics

Company background

Harmony Prenatal Test

Competitive advantage

Future endeavors

Interview with Tom Musci

  • Company background
  • Harmony Test
  • Competitive advantage
  • Future endeavors

CHAPTER 6: Natera

Company background

Panorama

Platform improvements

Validation

Challenges encountered

Competitive advantage

Future endeavors

Interview with Solomon Moshkevich

  • Company background
  • Panorama
  • Platform improvements
  • Validation
  • Challenges encountered
  • Customer feedback
  • Competitive advantage
  • Future endeavors

CHAPTER 7: Silicon Biosystems

Company background

DEPArray System

Challenges encountered

Competitive advantage

Future endeavors

Interview with Robert Proulx

  • Company background
  • DEPArray Platform
  • Challenges encountered
  • Customer feedback
  • Future endeavors

CHAPTER 8: Noninvasive Screening Test Specifications

 

Part III: Prenatal Complications

CHAPTER 9: Prenatal Complications

Preeclampsia

Preterm labor

CHAPTER 10: Metabolomic Diagnostics

Company background

Preeclampsia screening test

Competitive advantage

Future endeavors

Interview with Charles Garvey

  • Company background
  • Areas of research
  • Competitive advantage
  • Future endeavors

CHAPTER 11: NX PharmaGen 

Company background

NeXosome platform

Competitive advantage

Future endeavors

Interview questions with Dr. Alan Ezrin and Brian Brohman

  • Company background
  • Preterm labor assays
  • Challenges encountered
  • Competitive advantage
  • Future endeavors

 

Part IV: Demographic Survey

CHAPTER 12: Survey Results

Survey demographics

Areas of research

Challenges encountered

Applications being used for prenatal diagnostics

Competitive strategies

 

Part V: Company Directory: A list of companies working in Prenatal Diagnostics

 

References

About Cambridge Healthtech Institute